Agilent Opens Center of Excellence for Dissolution Products

Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) has inaugurated the Dissolution Center of Excellence in Craven Arms, UK, consolidating its dissolution business. This $6.32 billion revenue company aims to enhance innovation and manufacturing capabilities for dissolution products and services, focusing on virtual connectivity post-COVID-19. The facility will serve as a global hub, providing education and support for customers, ensuring improved access to expert assistance across time zones. This investment signifies Agilent's commitment to meeting the evolving needs of the pharmaceutical industry.

Positive

• Inauguration of the Dissolution Center of Excellence enhances Agilent's innovation capacity.
• Consolidation of dissolution business under one roof improves operational efficiency.
• Enhanced virtual connectivity caters to global customer needs.

Negative

• None.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom. The newly modernized premises will house the core of Agilent’s dissolution business, including research and development, quality, support, applications, marketing, and more. This investment allows all Agilent dissolution activities to be consolidated under one roof, facilitating the cooperation of all business segments and driving the mission of innovation for the next generation of dissolution products and services.

The COVID-19 pandemic has highlighted the need for improving virtual connectivity, with many companies seeking new ways to strengthen contact with customers. This expanded site will serve as a hub for Agilent’s dissolution customers around the world, providing education, training, application development, and both on-site and virtual demonstrations. These enhanced capabilities demonstrate Agilent’s adaptation to this new model of doing business while providing a channel for customers to easily access expertise and support.

Steve O’Donohue, director at the Craven Arms site, discussed the importance of the new center for Agilent's continuing commitment to dissolution. “The growth in our dissolution business has really driven the need for this larger facility,” he said. “Our new flagship site will enable us to develop a truly unified approach to dissolution for the future. The location will also facilitate greater innovation and manufacturing capabilities to support Agilent’s digital lab initiatives.”

This investment by Agilent also provides immediate value to their global dissolution customer base; Dan Spisak, dissolution marketing manager at Agilent, explained. "By centering all dissolution activities in the UK, customers from all time zones will have improved access to our team of experts, with the latest technology to virtually connect for education, training, troubleshooting, and all other types of dissolution testing assistance.”

Agilent have a comprehensive portfolio of dissolution testing technology and software meeting pharmaceutical industry requirements. For more information about Agilent’s dissolution testing portfolio, visit: agilent.com/en/product/dissolution-testing

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221012005089/en/

Catherine Kaye

Agilent Technologies

07775 410632

Catherine.kaye@agilent.com

Source: Agilent Technologies Inc.

FAQ

What is the significance of Agilent's new Dissolution Center in the UK?

The new Dissolution Center consolidates Agilent's dissolution business, fostering innovation and operational efficiency.

How does Agilent plan to improve customer support with the new facility?

The facility will enhance virtual connectivity, allowing greater access to expert assistance and education for global customers.

What are Agilent's revenue figures as of fiscal 2021?

Agilent generated $6.32 billion in revenue in fiscal 2021.

What services will the new Dissolution Center provide?

The center will offer training, application development, and virtual demonstrations related to dissolution testing.

How will the new center impact Agilent's business?

The center aims to support Agilent's digital lab initiatives and strengthen its dissolution product offerings.